Takayasu arteritis, Ann Intern Med, vol.120, pp.919-948, 1994. ,
Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients, Mayo Clin Proc, vol.88, pp.822-852, 2013. ,
Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup, Arthritis Care Res (Hoboken), vol.64, pp.1079-83, 2012. ,
Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study, Rheumatology (Oxford), vol.51, pp.882-888, 2012. ,
Biotherapies in large vessel vasculitis, Autoimmun Rev, vol.15, pp.544-51, 2016. ,
Efficacy of biologicaltargeted treatments in Takayasu arteritis: multicenter, retrospective study of 49 patients, Circulation, vol.132, pp.1693-700, 2015. ,
Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience, Circulation, vol.125, pp.813-822, 2012. ,
Tocilizumab in refractory Takayasu arteritis: a case series and updated literature review, Autoimmun Rev, vol.12, pp.1143-1152, 2013. ,
Biological treatments in giant cell arteritis & Takayasu arteritis, Eur J Intern Med, vol.50, pp.12-21, 2018. ,
Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis, J Clin Rheumatol, vol.20, pp.125-134, 2014. ,
Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review, Clin Exp Rheumatol, vol.34, pp.44-53, 2016. ,
One-year clinical and radiological evolution of a patient with refractory Takayasu's arteritis under treatment with tocilizumab, Clin Exp Rheumatol, vol.30, pp.98-100, 2012. ,
Sustained inflammation of the aortic wall despite tocilizumab treatment in two cases of Takayasu arteritis, Rheumatology (Oxford), vol.52, pp.1729-1760, 2013. ,
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled ,
, Ann Rheum Dis, vol.78, p.9, 2019.
Tocilizumab treatment in childhood Takayasu arteritis: case series of four patients and systematic review of the literature, Semin Arthritis Rheum, vol.46, pp.529-564, 2017. ,
Tocilizumab and refractory Takayasu disease: four case reports and systematic review, Autoimmun Rev, vol.17, pp.353-60, 2018. ,
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis, Ann Rheum Dis, vol.78, p.9, 2019. ,
The efficacy of tocilizumab for the treatment of Chinese Takayasu's arteritis, Clin Exp Rheumatol, vol.35, issue.103, pp.171-176, 2017. ,
Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients, Circulation, vol.136, pp.1114-1136, 2017. ,
Canadian Vasculitis network (CanVasc) nonglucocorticoid drugs for the treatment of Takayasu's arteritis: a systematic review and meta-analysis, Autoimmun Rev, vol.17, pp.683-93, 2018. ,
, Publisher's Note
, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations